These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 32241791)

  • 1. To consider or not antimalarials as a prophylactic intervention in the SARS-CoV-2 (Covid-19) pandemic.
    Spinelli FR; Ceccarelli F; Di Franco M; Conti F
    Ann Rheum Dis; 2020 May; 79(5):666-667. PubMed ID: 32241791
    [No Abstract]   [Full Text] [Related]  

  • 2. Chloroquine and hydroxychloroquine for COVID-19: implications for cardiac safety.
    Jeevaratnam K
    Eur Heart J Cardiovasc Pharmacother; 2020 Jul; 6(4):256-257. PubMed ID: 32347923
    [No Abstract]   [Full Text] [Related]  

  • 3. Chloroquine and hydroxychloroquine as available weapons to fight COVID-19.
    Colson P; Rolain JM; Lagier JC; Brouqui P; Raoult D
    Int J Antimicrob Agents; 2020 Apr; 55(4):105932. PubMed ID: 32145363
    [No Abstract]   [Full Text] [Related]  

  • 4. Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro.
    Wang M; Cao R; Zhang L; Yang X; Liu J; Xu M; Shi Z; Hu Z; Zhong W; Xiao G
    Cell Res; 2020 Mar; 30(3):269-271. PubMed ID: 32020029
    [No Abstract]   [Full Text] [Related]  

  • 5. Does lopinavir really inhibit SARS-CoV-2?
    Cattaneo D; Cattaneo D; Gervasoni C; Corbellino M; Galli M; Riva A; Gervasoni C; Clementi E; Clementi E
    Pharmacol Res; 2020 Aug; 158():104898. PubMed ID: 32438034
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Repurposing antimalarials and other drugs for COVID-19.
    Schlagenhauf P; Grobusch MP; Maier JD; Gautret P
    Travel Med Infect Dis; 2020; 34():101658. PubMed ID: 32247925
    [No Abstract]   [Full Text] [Related]  

  • 7. Remdesivir against COVID-19 and Other Viral Diseases.
    Malin JJ; Suárez I; Priesner V; Fätkenheuer G; Rybniker J
    Clin Microbiol Rev; 2020 Dec; 34(1):. PubMed ID: 33055231
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chloroquine hype is derailing the search for coronavirus treatments.
    Ledford H
    Nature; 2020 Apr; 580(7805):573. PubMed ID: 32332911
    [No Abstract]   [Full Text] [Related]  

  • 9. Characteristics of the Multiplicity of Randomized Clinical Trials for Coronavirus Disease 2019 Launched During the Pandemic.
    Kouzy R; Abi Jaoude J; Garcia Garcia CJ; El Alam MB; Taniguchi CM; Ludmir EB
    JAMA Netw Open; 2020 Jul; 3(7):e2015100. PubMed ID: 32658285
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Delayed Initiation of Remdesivir in a COVID-19-Positive Patient.
    Hillaker E; Belfer JJ; Bondici A; Murad H; Dumkow LE
    Pharmacotherapy; 2020 Jun; 40(6):592-598. PubMed ID: 32281114
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current pharmacological modalities for management of novel coronavirus disease 2019 (COVID-19) and the rationale for their utilization: A review.
    Giovane RA; Rezai S; Cleland E; Henderson CE
    Rev Med Virol; 2020 Sep; 30(5):e2136. PubMed ID: 32644275
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Are there any Therapeutic Options Currently Available for Wuhan Coronavirus?
    Carradori S
    Antiinflamm Antiallergy Agents Med Chem; 2020; 19(2):85-87. PubMed ID: 32213152
    [No Abstract]   [Full Text] [Related]  

  • 13. Race to find COVID-19 treatments accelerates.
    Kupferschmidt K; Cohen J
    Science; 2020 Mar; 367(6485):1412-1413. PubMed ID: 32217705
    [No Abstract]   [Full Text] [Related]  

  • 14. Rapid review for the anti-coronavirus effect of remdesivir.
    Li Z; Wang X; Cao D; Sun R; Li C; Li G
    Drug Discov Ther; 2020; 14(2):73-76. PubMed ID: 32378648
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Caution Needed on the Use of Chloroquine and Hydroxychloroquine for Coronavirus Disease 2019.
    Fihn SD; Perencevich E; Bradley SM
    JAMA Netw Open; 2020 Apr; 3(4):e209035. PubMed ID: 32330276
    [No Abstract]   [Full Text] [Related]  

  • 16. Arguments in favour of remdesivir for treating SARS-CoV-2 infections.
    Ko WC; Rolain JM; Lee NY; Chen PL; Huang CT; Lee PI; Hsueh PR
    Int J Antimicrob Agents; 2020 Apr; 55(4):105933. PubMed ID: 32147516
    [No Abstract]   [Full Text] [Related]  

  • 17. Progress in Studies on Structural and Remedial Aspects of Newly Born Coronavirus, SARS-CoV-2.
    Gupta SP
    Curr Top Med Chem; 2020; 20(26):2362-2378. PubMed ID: 32962613
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Remdesivir for patients with COVID-19].
    Augustin M; Hallek M; Nitschmann S
    Internist (Berl); 2020 Aug; 61(8):869-872. PubMed ID: 32572516
    [No Abstract]   [Full Text] [Related]  

  • 19. Audio Interview: Studying Potential Covid-19 Therapies.
    Rubin EJ; Baden LR; Morrissey S
    N Engl J Med; 2020 May; 382(19):e72. PubMed ID: 32379957
    [No Abstract]   [Full Text] [Related]  

  • 20. Treatment of SARS-CoV-2: How far have we reached?
    Ahsan W; Javed S; Bratty MA; Alhazmi HA; Najmi A
    Drug Discov Ther; 2020 May; 14(2):67-72. PubMed ID: 32336723
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.